EPISODE · Nov 17, 2017 · 1 MIN
APCC 2017 Interviews - Chris Sweeney 2
from Talking Urology Podcast · host Talking Urology
Chris Sweeney discusses which is best? Abiraterone vs docetaxal with ADT for hormone naïve metastatic prostate cancer
Embed this episode
NOW PLAYING
APCC 2017 Interviews - Chris Sweeney 2
0:00
1:35
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Talking Urology Podcast?
This episode is 1 minute long.
When was this Talking Urology Podcast episode published?
This episode was published on November 17, 2017.
Can I download this Talking Urology Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!